Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-20

FDA Approved: EPIDIOLEX — Supplemental Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Epidiolex (cannabidiol) submitted by Jazz Pharmaceuticals, Inc. The action updates the labeling related to the use o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDIOLEX (Cannabidiol)

Snippet

SUPPL AP for EPIDIOLEX (CANNABIDIOL)